Health Care/Hospital

Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit

Dr. Denlinger is currently NCCN's Chief Scientific Officer and previously served as Chair and Member of multiple NCCN Guidelines Panels—in charge of maintaining gold-standard evidence-based expert consensus cancer treatment recommendations. PLYMOUTH MEETING, Pa., Aug. 23, 2023 /PRNewswire/ -- To...

2023-08-23 20:06 1531

Innovent Announces 2023 Interim Results and Business Updates

Remarkable achievements with accelerated growth and improved efficiency to underpin sustainable growth ROCKVILLE, M.D. and SUZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and comme...

2023-08-23 19:38 4472

Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US

Two implants were successfully conducted as part of the FDA approved Early Feasibility Study inthe United States YOKNEAM, Israel, Aug. 23, 2023 /PRNewswire/ -- The heart teams at the Piedmont Heart Institute inAtlanta, Georgia, USA and the University of Virginia Health System inCharlottesville, ...

2023-08-23 18:07 1128

Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company

MELBOURNE, Australia, Aug. 23, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the half-year ended30 June 2023. All figures are in AUD$ unless otherwise stated.[1] Financial highlights * Total Group revenue $220.8M ...

2023-08-23 17:40 1332

USANA Philippines Celebrates Legacy of Wellness Empowerment With Enterprise Asia Linchpin of Asia Awards 2023

SINGAPORE, Aug. 22, 2023 /PRNewswire/ -- Founded in 1992 by microbiologist and immunologist Dr. Myron Wentz, USANA Health Sciences is a U.S.-based international direct-selling company that researches, manufactures, and sells premium, science-based supplements, personal care, and healthy living...

2023-08-23 17:06 1545

Leading by Inspiration: KPJ Tawakkal KL Specialist Hospital Triumphs with Asia Pacific Enterprise Award for its Exceptional Brand

SINGAPORE, Aug. 23, 2023 /PRNewswire/ -- KPJ Tawakkal KL Specialist Hospital (KPJ TWKL), a renowned name in the healthcare industry, has achieved yet another milestone by being honored with the prestigious Inspirational Brand Award at the Asia Pacific Enterprise Awards 2023 Malaysia. This recogni...

2023-08-23 15:18 1685

Green Living Starts Here: A Look at Practical Steps to Sustainability at Home

PASAY CITY, Philippines, Aug. 23, 2023 /PRNewswire/ -- Managing a household is a fulfilling yet tough, especially when aiming for a more sustainable way of life. Homemakers now understand the significance of living sustainably, not only for the environment but also for their family's health. L...

2023-08-23 14:40 2184

Waterdrop Insurance Marketplace Unveils Blue Ocean LifeTime Health Insurance, Paving the Way for Affordable Premium Healthcare Insurance Solutions

BEIJING, Aug. 23, 2023 /PRNewswire/ -- Waterdrop Insurance Marketplace, the insurance intermediary platform of Waterdrop Inc. ("Waterdrop", the "Company") (NYSE: WDH), a leading technology platform in the insurance and healthcare sectors with an emphasis on social impact, has rolled out Blue Ocea...

2023-08-23 12:12 2993

MGI Partners with NGeneBio to Advance Precision Medicine

SEOUL, South Korea, Aug. 23, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science and NGeneBio, a company specializing in next-generation sequencing-based diagnostic have signed a memorandum of understanding (MOU) to expand the commercial access...

2023-08-23 09:00 2265

Lynk Pharmaceuticals Announces Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Ankylosing Spondylitis

HANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (referred to as "Lynk Pharmaceuticals"), an innovative clinical stage company, announced positive topline data from a Phase II clinical trial of LNK01001 for the treatment of ankylosing spondylitis (AS). The study, led...

2023-08-23 08:00 2936

Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results

First patient dosed in a PEG-IFN-α controlled BRII-835 + PEG-IFN-α combination Phase 2 study for HBV functional cure First of several studies to investigate the potential of BRII-179 in enriching patients with strong intrinsic anti-HBsAg responses for curative treatments to start before the end ...

2023-08-22 22:00 3248

Paradigm Therapeutics Acquires Late Stage "Breakthrough Therapy" Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB)

'Topical Therapy for Treating the Wounds and Lesions on the Entire Skin Surface' MT PLEASANT, S.C., Aug. 22, 2023 /PRNewswire/ -- Paradigm Therapeutics Inc., a biopharmaceutical company, today announced the completion of the acquisition of the worldwide rights of SD-101, a topical whole-body trea...

2023-08-22 21:13 2149

Ratchaphruek Hospital in Khon Kaen, Thailand Achieves GHA Accreditation with Excellence, Affirming Its World-Class Services for Medical Travelers

KHON KAEN, Thailand, Aug. 22, 2023 /PRNewswire/ -- Ratchaphruek Hospital in Khon Kaen province,Thailand, has achieved a significant milestone by being awarded Accreditation with Excellence for Medical Travel Services byGlobal Healthcare Accreditation (GHA). This accolade underscores Ratchaphruek ...

2023-08-22 18:00 1390

Berlin Heals Holding AG welcomes Dr. Felix Baader and Roland Diggelmann as new board members Final phase of ongoing CE study started

ZUG, Switzerland, Aug. 22, 2023 /PRNewswire/ -- Berlin Heals Holding AG (Berlin Heals), a Swiss medical technology company, is delighted to announce the appointments of Dr.Felix Baader and Roland Diggelmann as new members of the Board of Directors. Since 2014, the company has developed a complete...

2023-08-22 15:00 1596

Mammotome Launches the HydroMARK™ Plus Breast Biopsy Site Marker, an Innovation for Tissue Marker Displacement

CINCINNATI, Aug. 21, 2023 /PRNewswire/ -- Mammotome announced the launch of an innovative new HydroMARK™ Plus Breast Biopsy Site Marker designed to enhance ultrasound visibility, improve ease of locating, and mitigate displacement during surgical procedures.1,2,3,4 This device marks another great...

2023-08-21 22:00 1537

Expanse Medical Welcomes Shlomi Nachman to Board of Directors

PLEASANTON, Calif., Aug. 21, 2023 /PRNewswire/ -- Expanse Medical, the innovative medical device incubator founded by Eitan Konstantino with focus on global innovations, proudly announces the addition ofShlomi Nachman to its Board of Directors and the Board of its spinoff, Expanse ICE. Mr. Nachma...

2023-08-21 21:01 1726

Hummingbird Bioscience to Present Poster on HMBD-001 Combination Strategy for Squamous Non-Small Cell Lung Cancer at World Conference on Lung Cancer 2023

HOUSTON and SINGAPORE, Aug. 21, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced an upcoming poster presentation at the IASLC 2023 World Conference ...

2023-08-21 17:58 1525

magAssist's NyokAssist™️ granted Designation by the FDA as a Breakthrough Device

SUZHOU, China, Aug. 21, 2023 /PRNewswire/ -- Recently, magAssist's NyokAssist™ Interventional Ventricular Assist Device (hereinafter referred to as NyokAssist™), has been granted designation as a breakthrough device by the U.S. Food and Drug Administration (FDA) in Breakthrough Device Program. Th...

2023-08-21 14:34 2098

Everest Medicines Announces Partner Calliditas Therapeutics Receives FDA Priority Review for Full Approval of Nefecon® for the Treatment of IgA Nephropathy

SHANGHAI, Aug. 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company") announced today that U.S. Food and Drug Administration (FDA) has accepted the submission for the supplemental New Drug Application (sNDA) for Nefecon® from its partner Calliditas Therapeutics AB ...

2023-08-21 08:20 1989

Sisram Medical to Report H1 2023 Financial Results on August 23 and Hold a Conference Call on August 24

H1 2023 conference call to be held on August 24, at 8:00 a.m. Eastern Time HONG KONG, Aug. 20, 2023 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the " Group"), a global consumer wellness group featuring a first-of-it...

2023-08-20 10:14 3894
1 ... 107108109110111112113 ... 566